Back to Search Start Over

AN OPEN-LABEL, PHASE 2 STUDY TO EVALUATE THE ORAL COMBINATION OF IXAZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..7b155a96cf27dcbd782b1d054080dd1b